Deerfield Management Discloses New Position in ANI Pharmaceuticals Inc (ANIP)

James E. Flynn‘s Deerfield Management reported a new stake in ANI Pharmaceuticals Inc (NASDAQ:ANIP). With nearly 660,000 shares in ANI, the fund now owns 5.85% of the company’s aggregate common stock outstanding, according to a recent 13G filing with the Securities and Exchange Commission.

ANI Pharmaceuticals

Incorporated in 11, 2001, ANI Pharmaceuticals Inc (NASDAQ:ANIP) is an emerging integrated specialty pharmaceutical company which develops, manufactures, and markets branded and generic prescription pharmaceuticals made in the US. The company also performs contract manufacturing for some of the largest pharmaceutical companies in the world. Last month, the company announced the closing of its seasoned public offering, in which it has issued 1.62 million shares of common stock, at a price of $31.00 per share, grossing $50.00 million of equity capital.

In its financial results for 2013, ANI highlighted that it reached record net revenues of $10.50 million in the fourth quarter of the year, generating $30.00 million revenues, but $0.92 net losses for the full last year. In 2014, the company is expected to perform significantly better, with consensus estimates settling around net profits of $1.30 per share. On average, analysts suggest that investors buy shares of ANI Pharmaceuticals Inc (NASDAQ:ANIP), setting a target price of $38.00 per share, compared to the current price of around $30.50.

Healthcare focused investment fund, Deerfield Management, owns an equity portfolio valued at nearly $2.00 billion and invested almost entirely (around 97.00%) in the Healthcare Sector. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) represents the largest share in the fund’s equity portfolio, the fund holding a position of more than 4.10 million shares in the company. Deerfield also owns large positions in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Array Biopharma Inc (NASDAQ:ARRY), with the respective amounts of 1.50 million and 11.25 million shares.

Earlier in April, Deerfield Management revealed a stake in the newly public Trivascular Technologies Inc (NASDAQ:TRIV), which started trading the same day. Shortly afterwards, the fund raised its position to 1.70 million shares from the previously held 632,700 shares of the company. Recently, Deerfield boosted its ownership of  Insmed Incorporated (NASDAQ:INSM) to 3.04 million shares - 7.75% of the company’s common stock.

Disclosure: none.

Recommended reading:

James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)

Sandell Asset Management Surges Stake in Meritor Inc (MTOR)

James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!